Edge (GX-Edge) is a new point-of-care platform not yet tested in the field. In this proof-of-concept study conducted for the diagnosis of tuberculosis in communities living alongside two large rivers of the Brazilian Amazon, we demonstrate that GX-Edge implemented in boats to offer onsite testing is a feasible strategy to investigate potentially devastating diseases such as tuberculosis in difficult-to-reach populations, such as riverside communities.
No takes yet. Share an insight, caveat, or question.
Cordeiro‐Santos et al. (2020) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: